http://www.outlooktherapeutics.com
Outlook Therapeutics, Inc. Company Intro
NEWS JULY 17, 2020
Outlook Therapeutics Announces Closing of $1.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules More JULY 7, 2020
Outlook Therapeutics Completes Patient Enrollment for NORSE 2 Study of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) More
Industry
Healthcare
Outlook Therapeutics, Inc. Headquaters
7 Clarke Drive
Cranbury,08512
United States
Outlook Therapeutics, Inc. Share price
26 Jan 2021 02:18 GMT
$1.3500
0.02 (1.5 %)
Outlook Therapeutics, Inc. Market cap
$172.969 M
WMC RANKING
2021
Outlook Therapeutics, Inc. # 195
BiotechnologyLatest Outlook Therapeutics, Inc. News
11 Jan 2021
Karyopharm Therapeutics Inc. (NASDAQ:KPTI): Hidden Gems ...
The trading price of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) closed ... outlook, we see that the stock's PEG is 0, which symbolizes a positive outlook.
11 Jan 2021
Here's Why Abeona Therapeutics Inc. (NASDAQ:ABEO) is an Attractive Investment Right Now
The trading price of Abeona Therapeutics Inc. (NASDAQ:ABEO) closed lower ... outlook, we see that the stock's PEG is 0, which symbolizes a positive outlook.
11 Jan 2021
Is There a Dimmer Outlook Ahead for Gevo Inc. (GEVO)?
Press Release reported on 01/07/21 that Thinking about buying stock in 3D Systems, Nio, Orchard Therapeutics, Check Cap, or Gevo? Get the hottest stocks to ...
WMC Market Score
WMC Market to Revenue Score
Outlook Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Outlook Therapeutics, Inc. | USD | $6,437 | $30,939 | $-50,795 | $1,730M | 195 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $584,960B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $352,840B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $627,500B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,200B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Outlook Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. Post vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Outlook Therapeutics, Inc. | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.47 | 10.77 | 0 | 0 | 0 | 66.25 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.60 | 100 | 0 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 3.19 | 0 | 0 | 0 | 88.50 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
